Erin Harris
Click here to email Erin.
Erin Harris is chief editor of Cell & Gene and a contributing editor to Life Science Leader magazine. She studied English and psychology at Lafayette College and has 20+ years of experience in B2B publishing. Erin spent 10 years covering and reporting on the adoption of information technology from a B2B perspective. She’s written on technology topics ranging from Big Data and analytics to security and e-commerce. In each case, her reporting centered on innovations that improved operational efficiencies, fostered interdepartmental collaboration, or enhanced supply chains. Currently, she writes actionable information for professionals involved in the development and commercialization of cell and gene therapies. She covers the entire product lifecycle from basic research to commercialization. Erin has interviewed executives from Fortune 500 as well as startups. She has moderated panel discussions and has spoken at numerous industry events from large conferences to niche forums.
ARTICLES BY ERIN HARRIS
-
![300_200-23_10_cgl_coldchain_webinar_1920x1080]( "Video Clips From Cell & Gene Live: Optimizing Your Cold Chain For Cell Therapies")
Video Clips From Cell & Gene Live: Optimizing Your Cold Chain For Cell Therapies11/30/2023For your convenience, we’ve broken down our Cell & Gene Live, Optimizing Your Cold Chain for Cell Therapies, into bite-size video clips by topic.
-
![Preview-GettyImages-1206045787]( "A Sneak Peek At Providence Therapeutics On Cell & Gene: The Podcast")
A Sneak Peek At Providence Therapeutics On Cell & Gene: The Podcast11/29/2023On an upcoming episode of Cell & Gene: The Podcast, I talk to Robert Georgantas III, Ph.D., of Providence Therapeutics, about their mRNA vaccine therapies. Here's a preview of our conversation.
-
![AML Acute myeloid leukemia-GettyImages-1337752576]( "Vor Bio Shares Progress For Patients with AML")
Vor Bio Shares Progress For Patients with AML11/17/2023I talked to Dr. Robert Ang, President and Chief Executive Officer at Vor Bio about the company's VBP101 study for trem-cel in patients with acute myeloid leukemia (AML)
-
![AI-Artifical Intelligence-GettyImages-1297832671]( "The Eye: A Candidate For Modifier Gene Therapy")
The Eye: A Candidate For Modifier Gene Therapy11/17/2023Ocugen's Chairman, CEO and Co-founder, Shankar Musunuri ,Ph.D., MBA, provides an update on OCU400 and other ongoing trials, why the eye is a good target for gene therapy, the outlook for retinal gene therapy, and more.
-
![23_08_CGL_CGTWorkflow_Webinar_1200x628_OD (1)]( "Video Clips From Cell & Gene Live: Regulating The CGT Workflow To Improve Patient Safety")
Video Clips From Cell & Gene Live: Regulating The CGT Workflow To Improve Patient Safety10/31/2023Here is a breakdown of original 60-minute Cell & Gene Live, Regulating the CGT Workflow to Improve Patient Safety, into video segments by topic.
-
![Sneak Peak]( "A Sneak Peek At REGENXBIO On Cell & Gene: The Podcast")
A Sneak Peek At REGENXBIO On Cell & Gene: The Podcast10/30/2023REGENXBIO's CEO, President, and Director, Ken Mills and I sat down to record an upcoming episode of Cell & Gene: The Podcast. Here's a sneak peak of the episode.
-
![22_01_CGPodcast_1200x628_Ep59]( "Highlights from In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg")
Highlights from In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg10/27/2023Umoja Biopharma’s Dr. Andrew Scharenberg joined me as my guest on a recent episode of Cell & Gene: The Podcast to discuss the evolution of in vivo CAR-T cell therapeutics. Here are highlights from our conversation.
-
![cell gene meeting on the mesa]( "ARM’s 2023 Meeting On The Mesa: Data, Ethics, And More")
ARM’s 2023 Meeting On The Mesa: Data, Ethics, And More10/19/2023ARM's 2023 Meeting on the Mesa was chock full of informative sessions, impactful conversations, partnering opportunities, and peer networking. Here's a brief recap.
-
![September 2023 calendar-GettyImages-1421228313]( "September's Top Content On Cell & Gene")
September's Top Content On Cell & Gene9/29/2023Here is a glimpse of the impactful content, in various formats, Cell & Gene delivered this month.
-
![resume recap interview-GettyImages-1637816598]( "Dr. Jim Wilson At LSPA’s Life Sciences Future Conference")
Dr. Jim Wilson At LSPA’s Life Sciences Future Conference9/28/2023LSPA's Life Science Future event included a plenary session featuring Jim Wilson Ph.D., M.D., Director, Gene Therapy Program Professor of Medicine and Pediatrics, Perelman School of Medicine at the University of Pennsylvania. Here's a recap of that session.
